Nishant N. Vaikath

Hamad bin Khalifa University — QA

Medicine · Health Sciences

25h-index2.6kcitations60works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(43), Neurological disorders and treatments(24), Alzheimer's disease research and treatments(13), Botulinum Toxin and Related Neurological Disorders(10), SARS-CoV-2 and COVID-19 Research(6)

Publications60 total

Retraction Note: Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts
BMC Complementary Medicine and Therapies·2025Open Access
Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies
Journal of Parkinson s Disease·2025· 3 citedOpen Access
Longitudinal cellular and humoral immune responses following COVID-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar
Frontiers in Immunology·2025· 2 citedOpen Access
In-house assays for detecting anti-SARS-CoV-2 antibodies in serum and urine: Correlation with COVID-19 severity from a cohort study in Qatar
Journal of Infection and Public Health·2025Open Access
Quantitative Measurements of α-Synuclein Seeds in CSF Inform Diagnosis of Synucleinopathies
2025Open Access
Retraction Notice to “Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy” [Neurobiology of Disease 104 (2017) 85–96]
Neurobiology of Disease·2025Open Access
Longitudinal cellular and humoral immune responses following Covid-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar.
2024Open Access
Retraction Notice to: Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson’s Disease and Other Brain Disorders
Molecular Therapy·2024Open Access
Retraction Notice to: Corrigendum to “Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson’s Disease and Other Brain Disorders”
Molecular Therapy·2024Open Access
Structural insights into the unique recognition module between α‐synuclein peptide and nanobody
Protein Science·2023· 4 citedOpen Access
Auto-immunoproteomics analysis of COVID-19 ICU patients revealed increased levels of autoantibodies related to the male reproductive system
Frontiers in Physiology·2023· 8 citedOpen Access
Screening for Novel Inhibitors of Amyloid Beta Aggregation and Toxicity as Potential Drugs for Alzheimer’s Disease
International Journal of Molecular Sciences·2023· 5 citedOpen Access
Assessment of Aggregated and Exosome-Associated α-Synuclein in Brain Tissue and Cerebrospinal Fluid Using Specific Immunoassays
Diagnostics·2023· 16 citedOpen Access
Uncovering a neurological protein signature for severe COVID-19
Neurobiology of Disease·2023· 3 citedOpen Access
Referee report. For: Identification of high-performing antibodies for Superoxide dismutase [Cu-Zn] 1 (SOD1) for use in Western blot, immunoprecipitation, and immunofluorescence [version 2; peer review: 1 approved]
Faculty of 1000 Research Ltd·2023Open Access
Production of α-Synuclein Fibrillar-Specific scFv from Inclusion Bodies
Methods in molecular biology·2023
Referee report. For: The identification of high-performing antibodies for Superoxide dismutase [Cu-Zn] 1 (SOD1) for use in Western blot, immunoprecipitation, and immunofluorescence [version 1; peer review: 1 approved with reservations]
Faculty of 1000 Research Ltd·2023Open Access
Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers
International Journal of Molecular Sciences·2022· 15 citedOpen Access
Inhibition of α-Synuclein Seeding-Dependent Aggregation by ssDNA Aptamers Specific to C-Terminally Truncated α-Synuclein Fibrils
ACS Chemical Neuroscience·2022· 13 cited
α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity
Proceedings of the National Academy of Sciences·2022· 189 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Omar M. A. El‐Agnaf(41), Nour K. Majbour(24), Simona S. Ghanem(10), Indulekha P. Sudhakaran(10), Houari Abdesselem(10), Daniel Erskine(9), Mustafa T. Ardah(7), Wilma D. J. van de Berg(7), Kostas Vekrellis(7), Issam Hmila(7), Vijay Gupta(5), Abdelilah Arredouani(5), Julie Decock(5), Takahiko Tokuda(4), Henk W. Berendse(4), Brit Mollenhauer(4), Muneera Fayyad(4), Ilham Y. Abdi(4), Seung‐Jae Lee(4), Omar MA El-Agnaf(4)